GGrantIndex
← Leaderboards

Sarah Beth Joseph

Univ Of North Carolina Chapel Hill

$6,435,061
Attributed
$9,615,151
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,615,151 · 6

By mechanism

R01$9,136,487 · 4
R56$382,192 · 1
F32$96,472 · 1

Top collaborators

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsInfectionVirusCd4 Positive T LymphocytesHiv-1BloodEvolutionCell TypeMacrophageMicrogliaBiological ModelsCollaborationsFuturePhenotypeLaboratoriesCell LineageT-LymphocyteCentral Nervous System InfectionsAffectNeuroaidsViralPersonsInflammatoryAntiretroviral Therapy

Grant awards (17)

Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance$1,132,909
R01 · FY2025 · AI · contact PI
Evolution and Latency of T-Tropic and M-Tropic HIV in People Infected with Subtype C$881,439
R01 · FY2025 · MH
Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance$1,167,948
R01 · FY2024 · AI · contact PI
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model$325,549
R01 · FY2024 · DA
Identifying Roadblocks to Antigen Expression and Enhancing Killing of HIV-Infected Cells That Are Refractory to Clearance$1,167,948
R01 · FY2023 · AI · contact PI
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates$629,961
R01 · FY2023 · MH · contact PI
Biology and Molecular Biology of the Evolution of Macrophage-Tropic HIV-1$382,192
R56 · FY2023 · AI
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model$325,549
R01 · FY2023 · DA
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates$653,159
R01 · FY2022 · MH · contact PI
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model$325,549
R01 · FY2022 · DA
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates$621,198
R01 · FY2021 · MH · contact PI
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model$325,549
R01 · FY2021 · DA
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates$677,839
R01 · FY2020 · MH · contact PI
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model$325,549
R01 · FY2020 · DA
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates$576,341
R01 · FY2019 · MH · contact PI
The Causes and Consequences of Complementation and Selfishness in Viruses$49,646
F32 · FY2008 · GM · contact PI
The Causes and Consequences of Complementation and Selfishness in Viruses$46,826
F32 · FY2007 · GM · contact PI